Viewing Study NCT03093402

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-03-01 @ 10:05 AM
Study NCT ID: NCT03093402
Status: COMPLETED
Last Update Posted: 2022-11-18
First Post: 2017-02-21
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: JBT-101 in Systemic Lupus Erythematosus (SLE)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus Erythematosus View
None SLE View
None Lupus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None JBT-101 (also known as lenabasum) View
None efficacy View
None musculoskeletal disease View
None randomized trial View